Stopping Statins at the End of Life

Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial - JAMA Internal Medicine - 2015

Brief Summary:

Among patients with life expectancy <1 year who are not on a statin for active CVD, discontinuation of statin therapy does not increase 60 day all-cause mortality when compared to statin continuation. Discontinuation may be associated with improved quality of life (QOL) and reduced medication costs.